Methylphenidate Effects on Symptoms of Attention Deficit Disorder in Adults

Archives of General Psychiatry

Volumn 41, Issue 11, 1984, Pages 1059-1063

  Mattes, Jeffrey A ^a,b   Boswell, Laine ^a   Oliver, Herman ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b Carrier Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADDICTION; ADOLESCENT; ADULT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MENTAL DISEASE; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG THERAPY; HYPERACTIVITY; THERAPY;

ADOLESCENT; ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MENTAL DISORDERS; METHYLPHENIDATE; MIDDLE AGE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; SUBSTANCE-RELATED DISORDERS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021522559     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1983.01790220049008     Document Type: Article

References (43)

1. Cantwell DB: Natural history and prognosis in the hyperactive child syndrome, in Cantwell DB (ed): The Hyperactive Child. New York, Spectrum Publications, 1975, pp 51-64.
2. Weiss G, Minde K, Werry JS, Douglas V, Nemeth E: Studies on the hyperactive child: VIII. Five-year follow-up. Arch Gen Psychiatry 1971; 24:409-414.
3. Weiss G, Hechtman L, Perlman T, Hopkins J, Wener A: Hyperactive as young adults. Arch Gen Psychiatry 1979;36:675-681.
4. Wender PH: The concept of adult minimal brain dysfunction, in Bellak L (ed): Psychiatric Aspects of Minimal Brain Dysfunction in Adults. New York, Grune & Stratton Inc, 1979, pp 1-15.
5. Wender PH, Reimherr FW, Wood DR: Attention deficit disorder in adults. Arch Gen Psychiatry 1981;38:449-456.
6. Borland B, Heckman H: Hyperactive boys and their brothers: A 25-year follow-up study. Arch Gen Psychiatry 1976;33:669-675.
7. Borland BL: Social adaptation in men who were hyperactive: A follow-up study of hyperactive boys and their brothers, in Bellak L (ed): Psychiatric Aspects of Minimal Brain Dysfunction in Adults. New York, Grune & Stratton Inc, 1979, pp 45-59.
8. Eisenberg L: The hyperkinetic child and stimulant drugs. Dev Med Child Neurol 1966;8:593-598.
9. Minde K, Lewin D, Weiss G, Lovigueur H, Douglas V, Sykes E: The hyperactive child in elementary school: A five-year, controlled follow-up. Except Child 1971;38:215-221.
10. Minde K, Weiss G, Mendelson N: A five-year follow-up study of 91 hyperactive school children. J Am Acad Child Psychiatry 1972;11:595-610.
11. Stewart M, Pitts F, Craig A, Dieurf A: The hyperactive child syndrome. Am J Orthopsychiatry 1966;36:861-867.
12. Mendelson W, Johnson J, Stewart M: Hyperactive children as teenagers: A follow-up study. J Nerv Ment Dis 1972;153:273-279.
13. Cantwell D: Psychiatric illness in the families of hyperactive children. Arch Gen Psychiatry 1972;27:414-417.
14. Cantwell DB: Genetic studies of hyperactive children: Psychiatric illness in biological and adopting parents, in Fieve RR, Rosenthal D, Brill H (eds): Genetic Research in Psychiatry. Baltimore, The Johns Hopkins Press, 1975, pp 259-272.
15. Morrison J, Stewart M: A family study of the hyperactive chlid syndrome. Biol Psychiatry 1971;3:189-195.
16. Morrison J, Stewart M: The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 1973;28:888-891.
17. Gittelman-Klein R: Review of clinical psychopharmacological treatment of hyperkinesis, in Klein DF, Gittelman-Klein R (eds): Progress in Psychiatric Drug Treatment. New York, Brunner/Mazel Inc, 1975, pp 661-674.
18. Mackay MC, Beck L, Taylor R: Methylphenidate for adolescents with MBD. NY State J Med 1973;173:550-554.
19. Safer D, Anlen RP: Stimulant drug treatment of hyperactive adolescents. Dis Nerv Syst 1975;36:454-457.
20. Arnold L, Strobl D, Weisenberg A: Hyperkinetic adult: Study of the ‘paradoxical’ amphetamine response. JAMA 1972;222:693-694.
21. Oettinger L: Proceedings of the Workshop on Evaluating Long-term Effects of Stimulant Drug Treatment. Chevy Chase, Md, Psychopharmacology Research Branch, National Institute of Mental Health, June 26, 1972, pp 150-176.
22. Bellak L (ed): Psychiatric Aspects of Minimal Brain Dysfunction in Adults. New York, Grune & Stratton Inc, 1979.
23. Mann H, Greenspan S: The identification and treatment of adult brain dysfunction. Am J Psychiatry 1976;133:1013-1017.
24. Wood DR, Reimherr FW, Wender PH, Johnson GE: Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 1976;33:1453-1462.
25. Jacobson A: The use of Ritalin in psychotherapy of depressions of the aged. Psychiatry Q 1958;32:474-485.
26. Landman ME, Reisig R, Perlman M: A practical mood stimulant. J Med Soc NJ 1958;55:155-158.
27. Kiloh LG, Neilson M, Andrews G: Response of depressed patients to methylamphetamine. Br J Psychiatry 1974;125:496-499.
28. Conners CK: A teacher rating scale to use in drug studies with children. Am J Psychiatry 1969;126:884-888.
29. McNair DM, Loss M, Droppleman LF: Manual for the Profile of Mood States. San Diego, Calif, Educational and Industrial Testing Service, 1971.
30. Derogatis LR, Lipman RS, Covi L: SCL-90: An outpatient psychiatric rating scale. Psychopharmacol Bull 1973;9:13-27.
31. Gough H: California Personality Inventory. Palo Alto, Calif, Consulting Psychologists Press, 1957.
32. Parent questionnaire, in ECDEU Assessment Battery for Pediatric Psychopharmacology. Early Clinical Drug Evaluation Unit, National Institute of Mental Health, Psychopharmacology Research Branch, 1973.
33. Pharmacotherapy of Children. US Dept of Health, Education, and Welfare publication (HSM) 73-9002. 1975, pp 68-70.
34. Willner AE: Towards development of more sensitive clinical tests of abstraction: The analogy test. Proc Am Psychol Assoc 1970;5:553-554.
35. Willner AE: Willner Instant Similarities Test. New York, Cognitive Tests Service, 1971.
36. Sloan W: The Lincoln-Oseretsky motor development scale. Genet Psychol Monogr 1955;51:183-252.
37. Endicott J, Spitzer RL: The Schedule for Affective Disorders and Schizophrenia: A diagnostic interview. Arch Gen Psychiatry 1978;35:837-844.
38. Endicott J, Cohen J, Nee J, Fleiss J, Sarantokos S: Hamilton Depression Rating Scale: Extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1981;38:98-103.
39. Endicott J, Spitzer RL: Current and past psychopathology scales (CAPPS). Arch Gen Psychiatry 1972;27:678-687.
40. Chess S, Thomas A, Birch H: Distortions in developmental reporting made by parents of behaviorally disturbed children. J Am Acad Child Psychiatry 1966;5:226-234.
41. Klein DF, Gittelman R, Quitkin F, Rifkin A: Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children, ed 2. Baltimore, Williams & Wilkins Co, 1980, pp 691-692.
42. Rapoport JL, Buchsbaum MS, Zohn TP, Weingartner H, Ludlow C, Mikkelson EJ: Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science 1978;199:560-563.
43. Yakovlev PI, Lecours AR: The myelogenetic cycles of regional maturation of the brain, in Minkowski A (ed): Regional Development of the Brain in Early Life. Oxford, England, Blackwell Scientific Publications, 1967, pp 3-70.